Next generation flexible & integrate system for the lab

Biolumi CX8

The in vitro diagnostic testing volume is growing globally due to the occurrence of the pandemic, increasing the need for tests, and bringing more challenges in quality and reliability. People require more efficiency, higher quality, lower cost expending, integration, and intellectualization of IVD instruments, and that is what Snibe’s goal is to provide. With the demand and needs of the Indian market, Snibe has continually established significant business with Indian customers and provided better solutions to its customers.

Biochemistry and immunoassay remain an essential part of in vitro diagnostic area. Snibe stays focused on CLIA and biochemistry R&D, seizing every opportunity to develop the technology of instruments, and bringing the best experience to customers. Inspired by the feedback of customers, based on market requirements, Snibe has launched the newly integrated system Biolumi CX8, a flexible labs solution that targets the customer’s pain points.

The newly compact integrated system Biolumi CX8 is a flexible and compact integrated system, combining one of the fastest immunoassay systems, MAGLUMI X8, and the smart biochemical system Biossays C8, with super-high throughput in a small footprint, providing the workflow, integration, and centralization of operation to meet different requirements.

Efficiency. Biolumi CX8 has super-high throughput to meet large-volume testing demands. Configurable to integrate with decapper module, no manual operation is required. Dedicated STAT sample rack channel to process emergency samples efficiently. What’s more, Biolumi CX8 provides many reagent positions to deliver both multiple biochemistry and immunoassay tests in the same time run to save time.

Convenience. Biolumi CX8’s intelligent consumable loading technology reduces manual work and the multiple built-in touchpads on each module. Moreover, the multidimensional indicator lights in Biossays C8 and MAGLUMI X8 allow operators to check the status far away from the analyzer.

Reliability. In Biolumi CX8, proven magnetic microbeads separation and ABEI labeling techniques are provided to improve accuracy, high-quality grating technology to ensure stability and consistency, and high-end tech sample pipetting with disposal tips to avoid cross-contamination. All of these undertake the reliability of the Biolumi CX8.

Flexibility. Biolumi CX8 can be customized according to needs, supporting up to four instruments connected, and covering the requirements of different laboratories. Biolumi CX8 can also link with laboratory automation system (TLA/LAS), a fully-automation total laboratory solution.

The Biolumi CX8 system combines one of the fastest CLIA instruments MAGLUMI X8 and the smart biochemical instrument Biossays C8. Let us have a quick look at that fantastic analyzer.

MAGLUMI X8
MAGLUMI X8 is a fully-auto CLIA analyzer target for large-test-volume labs and hospitals, possesses a super-high throughput with 600 T/H, and can take up to 2400 T/H when four combined. MAGLUMI X8 has 42 reagent positions and 300 sample positions. Both reagent and sample areas have no-pause loading and unloading functions, and a refrigeration model.

For reliability, MAGLUMI X8 uses the ADP module with the one-time TIPs for sampling and two titanium reagent needles coated with TEFLON. With these features, cross-contamination will not occur. In incubation and washer, MAGLUMI X8 supports non-contact mixing mode to anti-carryover. The 360° constant incubation ensures accurate, quick, and uniform incubation, and the 4-group independent units reduce non-specific binding.

Biossays C8
Biossays C8 is a powerful and versatile biochemistry analyzer that offers high throughput with 1600 T/H and a wide range of test parameters. It has 300 sample positions and two reagent trays, each with 72 reagent positions. Additionally, Biossays C8 possesses an ISE module, allowing for analyzing electrolytes at 300 tests per hour, which is handy in monitoring patients with electrolyte disorders.

The launch of the Biolumi CX8 represents a significant step forward for us in the IVD industry. Innovation is always Snibe’s belief. Snibe’s portfolio is constantly evolving to include new and innovative tests to meet the changing needs of the healthcare industry. Snibe will continue to pay attention to the healthcare of India, and offer better solutions for everyone in need.